Brief: Knight Therapeutics assumes commercial activities and re-launches Exelon in Brazil
15/08/2022 12:35
Aug 15 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS ASSUMES COMMERCIAL ACTIVITIES AND
RE-LAUNCHES EXELON IN BRAZIL
Source text for Eikon: ID:nGNX723RXq
Further company coverage: GUD.TO
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil